Dr. Diba Kadivar | Inorganic Chemistry | Best Researcher Award

Published on 15/03/202515/03/2025 by Chemistry Awards

Dr. Diba Kadivar | Inorganic Chemistry| Best Researcher Award

Dr. Diba Kadivar | Inorganic Chemistry| Ph. D. graduate in inorganic chemistry at chemistry and chemical engineering research center of iran , Iran

Dr. Diba Kadivar is a Ph.D. graduate in Inorganic Chemistry with extensive expertise in anticancer platinum complexes. She has been serving as a technical assistant at the Iranian Food and Drug Administration (IFDA) for over eight years, contributing to pharmaceutical research and regulatory affairs. Dr. Kadivar has conducted significant studies on the synthesis, characterization, and biological activity of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and aliphatic N-substituted glycine derivatives on platinum complexes’ pharmacological properties. She has published multiple papers in reputed journals and actively collaborates on cancer cell line studies. Passionate about innovative drug discovery, she has contributed to the development of metal-based nanocomplexes for potential therapeutic applications. Dr. Kadivar remains committed to advancing medicinal inorganic chemistry through her research and collaborations, aiming to enhance the effectiveness of anticancer therapies while minimizing side effects.

Professional Profile :

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Dr. Diba Kadivar is a distinguished researcher in inorganic chemistry, specializing in anticancer platinum complexes. With a Ph.D. in inorganic chemistry and eight years of experience as a technical assistant at the Iranian Food and Drug Administration (IFDA), she has made notable contributions to the development of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and the role of aliphatic N-substituted glycine derivatives in enhancing the biological activities of platinum complexes. She has published in reputable journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications, with a citation index of 18. Dr. Diba Kadivar’s innovative research on platinum-based anticancer drugs, scientific contributions, and expertise in inorganic medicinal chemistry make her highly suitable for the “Best Researcher Award.” Her work advances cancer treatment strategies, and her publications demonstrate scientific excellence and impact in medicinal chemistry.

🎓Education:

Dr. Diba Kadivar pursued her doctoral studies in Inorganic Chemistry, specializing in metal-based drug development and anticancer platinum complexes. Her academic journey has been marked by a strong foundation in medicinal chemistry, with a keen interest in exploring the role of isomerism in drug efficacy. During her Ph.D., she conducted extensive research on platinum complexes with glycine derivatives, focusing on their interaction with DNA and anticancer properties. Her work involved molecular docking, dynamic simulations, and in-vitro studies to evaluate the pharmacological potential of these compounds. Through her research, she contributed to the field of coordination chemistry and its applications in medicine. She has actively participated in international conferences, presenting her findings on novel platinum-based therapies. With a passion for drug discovery, Dr. Kadivar continues to apply her expertise in chemistry to enhance the effectiveness of anticancer agents.

🏢Work Experience:

Dr. Diba Kadivar has accumulated over eight years of professional experience as a technical assistant at the Iranian Food and Drug Administration (IFDA). In this role, she has been actively involved in regulatory affairs, pharmaceutical analysis, and drug quality control, ensuring the safety and efficacy of therapeutic compounds. Alongside her administrative responsibilities, she has played a vital role in cancer research, working in laboratory settings to study platinum-based anticancer agents. Her expertise extends to working with cancer and normal cell lines, contributing to drug screening and cytotoxicity assays. Additionally, she has been involved in synthesizing and characterizing novel platinum complexes, focusing on their pharmacological interactions. Dr. Kadivar also collaborates with academic institutions and research centers, aiming to bridge the gap between regulatory science and drug discovery. Her hands-on experience in both research and regulatory affairs makes her a key contributor to pharmaceutical advancements in Iran.

🏅Awards:

Dr. Diba Kadivar has been recognized for her contributions to inorganic and medicinal chemistry, particularly in the field of platinum-based anticancer research. She has received accolades for her pioneering work on the role of geometric isomerism in anticancer drug efficacy. Her research has been acknowledged at national and international scientific conferences, where she has been invited as a speaker and presenter. She has also played a key role in regulatory initiatives at the Iranian Food and Drug Administration, contributing to drug quality assurance and research-based policy-making. Additionally, her publications in esteemed journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications have received notable citations, highlighting her impact on the field. Dr. Kadivar’s dedication to advancing cancer therapy and pharmaceutical sciences continues to earn her recognition among her peers, further solidifying her reputation as an innovative researcher in medicinal inorganic chemistry.

🔬Research Focus:

Dr. Diba Kadivar’s research primarily revolves around the synthesis, characterization, and biological evaluation of platinum-based anticancer complexes. She investigates the impact of geometric isomerism on drug efficacy, focusing on how structural variations influence DNA interactions and cytotoxicity. Her studies explore novel ligand designs, particularly aliphatic N-substituted glycine derivatives, to enhance the pharmacological properties of platinum complexes. In addition to drug synthesis, she conducts in-vitro studies on cancer and normal cell lines to assess the cytotoxic potential of these compounds. She is also involved in molecular docking and dynamic simulations to predict drug interactions at the molecular level. Furthermore, she has worked on calcium, magnesium, copper, and zinc glycine edible nanocomplexes, aiming to develop biocompatible metal-based therapies. Through her interdisciplinary approach, Dr. Kadivar contributes to bridging chemistry and medicine, paving the way for new, targeted anticancer treatments with improved therapeutic outcomes.

Publication Top Notes:

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

Authors: K. Nikoofar, D. Kadivar, S. Shirzadnia

Citations: 13

Year: 2014

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Authors: D. Kadivar, M. E. Moghadam, B. Notash

Citations: 5

Year: 2024

Novel anticancer agents, Pt complex with 1-pyrrolidineacetic acid ligand: Synthesis, biological activity, DNA interaction, molecular docking, and dynamic study

Authors: D. Kadivar, M. E. Moghadam, M. Rezaeisadat

Year: 2025

Dr. Jean Moto Ongagna | Theoretical Chemistry | Catalysis Award

Published on 17/02/202517/02/2025 by Chemistry Awards

Dr. Jean Moto Ongagna | Theoretical Chemistry | Catalysis Award

Dr. Jean Moto Ongagna | Theoretical Chemistry | Lecturer – University of Douala-Cameroon , Cameroon

Dr. Jean Moto Ongagna is a Cameroonian researcher specializing in Theoretical chemistry and Computational Chemistry . He obtained his Ph.D. from the University of Douala in 2021. His expertise spans Density Functional Theory (DFT), Pharmacokinetics (ADMET), Molecular Docking, Molecular Dynamics (MD), and ab initio Molecular Dynamics (ADMP). Dr. Ongagna has contributed significantly to computational chemistry, particularly in studying metal complexes, chemical bonding, and reaction mechanisms. He has participated in prestigious international conferences and workshops, presenting groundbreaking research on chemical bonding interactions. With numerous publications in high-impact journals such as RSC Advances and the International Journal of Quantum Chemistry, his work advances the understanding of transition metal complexes and their applications. He actively collaborates with researchers worldwide and is dedicated to developing computational tools for chemical and biological systems.

Professional Profile :

Orcid

Summary of Suitability for Award:

Dr. Jean Moto Ongagna is an outstanding candidate for the “Catalysis Awards”, given his significant contributions to computational catalysis and theoretical chemistry. His research extensively applies Density Functional Theory (DFT), Quantum Chemical Calculations, and Molecular Dynamics (MD) to investigate transition metal complexes, non-standard chemical bonding, and catalytic reaction mechanisms. His studies provide deep insights into metal-ligand interactions, catalytic efficiency, and reaction pathways, which are fundamental for designing novel catalytic systems. Dr. Jean Moto Ongagna’s research in computational catalysis, transition metal chemistry, and theoretical modeling aligns perfectly with the objectives of the “Catalysis Awards”. His work advances the understanding of catalyst behavior, reaction mechanisms, and molecular interactions, making a substantial impact on modern catalysis research. His ability to integrate quantum chemistry tools with catalytic design positions him as a highly suitable candidate for this prestigious recognition.

🎓Education:

Dr. Jean Moto Ongagna pursued his higher education at the University of Douala, Cameroon. He earned a Ph.D. in Theoretical and Computational Chemistry (2021), focusing on Density Functional Theory (DFT) and molecular simulations. In 2016, he completed his Master’s degree in the same field, where he explored the computational analysis of metal-ligand interactions. His Bachelor’s degree in Physical Chemistry (2013) laid the foundation for his research on quantum chemistry and molecular modeling. Before university, he completed his GCE Advanced Level (Baccalauréat D) in 2008 at Laic Private College “La Liberté” in Douala. His education equipped him with expertise in quantum chemistry, molecular docking, and theoretical modeling, enabling him to contribute to cutting-edge research. Throughout his academic journey, he attended specialized workshops and conferences to enhance his skills in computational chemistry, continuously refining his expertise in quantum simulations and advanced chemical theories.

🏢Work Experience:

Dr. Jean Moto Ongagna has extensive experience in Theoretical chemistry and Computational Chemistry, with expertise in Density Functional Theory (DFT), Molecular Docking, Pharmacokinetics (ADMET), and ab initio Molecular Dynamics (ADMP). He has actively participated in international conferences, presenting research on transition metal complexes, chemical bonding, and molecular interactions. He has contributed to significant projects involving the computational study of catalysts, biomolecular interactions, and pharmaceutical compounds. Dr. Ongagna has also collaborated with renowned institutions and researchers worldwide, publishing extensively in high-impact journals. His research experience includes developing and applying quantum chemical tools for investigating metal-ligand interactions and reaction mechanisms. He has been involved in multiple computational chemistry workshops, enhancing his knowledge of secondary metabolite discovery, quantum topology, and electronic structure theory. His contributions have led to a deeper understanding of non-standard chemical bonding and have implications for catalysis, drug design, and materials science.

🏅Awards:

Dr. Jean Moto Ongagna has received multiple recognitions for his contributions to Theoretical and Computational Chemistry. He has been invited as a speaker at international conferences, including the 4th Commonwealth Chemistry Posters (2023) and the Virtual Conference on Chemistry and Its Applications (2021, 2022). His research on transition metal complexes and quantum chemistry has been published in high-impact journals such as RSC Advances and the International Journal of Quantum Chemistry. He has received accolades for his computational investigations on catalytic and biomolecular systems, contributing to the advancement of quantum chemical methodologies. His participation in scientific workshops at the University of Buea (Cameroon) and Technische Universität Dresden (Germany) further highlights his academic excellence. His continuous engagement in international scientific discussions and collaborations has strengthened his reputation as a leading researcher in quantum chemistry and molecular modeling.

🔬Research Focus:

Dr. Jean Moto Ongagna’s research focuses on Theoretical and Computational Chemistry, particularly Density Functional Theory (DFT), Quantum Chemical Calculations, Molecular Docking, Pharmacokinetics (ADMET), and Molecular Dynamics (MD). He specializes in studying transition metal complexes, non-standard chemical bonds, and catalytic reactions. His work involves topological analysis of chemical interactions using advanced computational techniques such as Quantum Theory of Atoms in Molecules (QTAIM), Energy Decomposition Analysis (EDA), and Natural Bond Orbital (NBO) analysis. He has made significant contributions to understanding palladium complexes, Diels–Alder reactions, and bioactive compounds. His research extends to computational drug discovery, antimicrobial compounds, and bioinorganic chemistry, aiming to bridge the gap between theoretical modeling and experimental applications. By integrating quantum chemical methods with molecular simulations, his studies provide valuable insights into reaction mechanisms, electronic structures, and potential applications in pharmaceuticals, catalysis, and material science.

Publication Top Notes:

Deciphering the Influence of Alkylene Bridged and Chelating Mode on Pd—C and Pd—X (X = Cl, Br, and I) Bonding Interaction Within Bis‐(NHC)‐Palladium Complexes Using Quantum Chemistry Tools

Authors: Gaël Mouzong D’Ambassa, Jean Moto Ongagna, Adjieufack Abel Idrice, Désiré Bikele Mama

Year: 2024

Computational Exploration of the Impact of Low‐Spin and High‐Spin Ground State on the Chelating Ability of Dimethylglyoxime Ligand on Dihalo Transition Metal: A QTAIM, EDA, and CDA Analysis

Authors: Daniel Lissouck, Suzane Leonie Djendo Mazia, Gaël Mouzong D’Ambassa, Jean Moto Ongagna

Year: 2024

Deciphering the Influence of PdII and PdIV Oxidation States on Non-Standard Chemical Bonds Within Bis(N-Heterocyclic Carbene) Complexes: Insights from DFT

Authors: Gaël Mouzong D’Ambassa, Jean Moto Ongagna, Adjieufack Abel Idrice, Désiré Bikele Mama

Year: 2024

Exploring the Mechanism of the Intramolecular Diels–Alder Reaction of (2E,4Z,6Z)-2(allyloxy)cycloocta-2,4,6-trien-1-one Using Bonding Evolution Theory